Newsletter
FDA Calendar
Market Data
Heat Map
Screener
Insider Trades
LOGIN
|
REGISTER
Index
Newsroom
Featured Stocks
Free Daily Newsletter
Stock Lists
See All Health Stock Lists
Biotechnology Stocks
Pharmaceutical Stocks
Big Pharma Stocks
Healthcare Stocks
Medical Stocks
Diagnostics & Research Stocks
Medical Device Stocks
Biotechnology News
Pharmaceutical News
Medical News
Healthcare News
Register
FDA Calendar
Market Data
Stock Screener
Insider Trades
Search
Logout
Newsroom
Featured Stocks
Stock Lists
Biotech
Pharma
Medical
Healthcare
Watch List
Recent Insider Transactions - Immunome (NASDAQ: IMNM)
Follow
NASDAQ:IMNM
Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ
IMNM
Immunome
Tsai Philip
/
officer: Chief Technical Officer
07/29/2025
Buy
$10.60
190,000
$2.014M
190,000
NASDAQ
IMNM
Immunome
Rosett Max
/
officer: Chief Financial Officer
07/29/2025
Buy
$10.60
207,000
$2.194M
207,000
NASDAQ
IMNM
Immunome
Lechleider Robert
/
officer: Chief Medical Officer
07/29/2025
Buy
$10.60
242,000
$2.565M
242,000
NASDAQ
IMNM
Immunome
Horn Kinney
/
officer: CHIEF BUSINESS OFFICER
07/29/2025
Buy
$10.60
161,000
$1.707M
161,000
NASDAQ
IMNM
Immunome
Higgins Jack
/
officer: Chief Scientific Officer
07/29/2025
Buy
$10.60
196,000
$2.078M
196,000
NASDAQ
IMNM
Immunome
SIEGALL CLAY B
/
director, officer: President and CEO
07/29/2025
Buy
$10.60
800,000
$8.480M
800,000
NASDAQ
IMNM
Immunome
Stoneman Sandra G.
/
officer: CHIEF LEGAL OFFICER & GC
07/29/2025
Buy
$10.60
190,000
$2.014M
190,000
Research Tools
Stock Screener
FDA Catalyst Calendar
Insider Transactions
Life Science Stock Lists
All Life Science Stocks
News & Announcements
All Life Science News
Clinical Trial News
Company FDA Updates
Mergers & Acquisitions
Search News & Events
Popular Topics
Top Stocks in 2025
Big Pharma Stocks
Artificial Intelligence
Obesity Drugs
Psychedelic Stocks
Miscellaneous
Free Daily Newsletter
Follow Us On X
Advertise
Privacy Policy
Disclaimer
Tweet
Share
Share
Share
Share
Sign Up To Get Daily
Life Science News
Register
or
Login
to Access Entire Platform.